FALLBACK SOLO Drug Patent Profile
✉ Email this page to a colleague
When do Fallback Solo patents expire, and when can generic versions of Fallback Solo launch?
Fallback Solo is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in FALLBACK SOLO is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fallback Solo
A generic version of FALLBACK SOLO was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FALLBACK SOLO?
- What are the global sales for FALLBACK SOLO?
- What is Average Wholesale Price for FALLBACK SOLO?
Summary for FALLBACK SOLO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,668 |
| Drug Prices: | Drug price information for FALLBACK SOLO |
| DailyMed Link: | FALLBACK SOLO at DailyMed |
Recent Clinical Trials for FALLBACK SOLO
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Erimos Pharmaceuticals | Phase 1 |
Pharmacology for FALLBACK SOLO
| Drug Class | Progestin Progestin-containing Intrauterine Device Progestin-containing Intrauterine System |
| Physiological Effect | Inhibit Ovum Fertilization |
US Patents and Regulatory Information for FALLBACK SOLO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | FALLBACK SOLO | levonorgestrel | TABLET;ORAL | 201446-001 | Jun 19, 2014 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
